Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Striae Distensae With Fractional Radiofrequency and Topical Tretinoin: An Intra-individual Study With Blinded Outcome Assessment

NCT05461755 is registered in ClinicalTrials.gov with Merete Haedersdal as lead sponsor.

NCT NCT05461755
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05461755 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Striae Distensae With Fractional Radiofrequency and Topical Tretinoin: An Intra-individual Study With Blinded Outcome Assessment
Lead sponsor
Merete Haedersdal
Phase
Phase 2
Overall status
Completed
Start date
November 22, 2022
Completion date
July 5, 2023
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

striae distensae